Medication use by early-stage breast cancer survivors: a 1-year longitudinal study
Identifieur interne : 001B05 ( Main/Exploration ); précédent : 001B04; suivant : 001B06Medication use by early-stage breast cancer survivors: a 1-year longitudinal study
Auteurs : Kep Yong Loh [Singapour] ; Terence Ng [Singapour] ; Chee Ping Lee [Singapour] ; Raymond Ng [Singapour] ; Alexandre Chan [Singapour]Source :
- Supportive Care in Cancer [ 0941-4355 ] ; 2015.
Abstract
The aim of this study is to characterize the patterns of medication use by early-stage breast cancer (ESBC) survivors from diagnosis to 1 year post-chemotherapy.
A single-center longitudinal study was conducted with ESBC patients diagnosed between December 2011 and June 2014. Data on the medication use of individual patients were retrieved from prescription databases, supplemented by records from the National Electronic Health Records. The data covered the period from ESBC diagnosis to 1 year post-chemotherapy. Medication types were classified according to the World Health Organization’s Anatomical Therapeutic Chemical classification system, and medication for chronic diseases was created by adapting a list of 20 chronic diseases provided by the U.S. Department of Human and Health Services.
Of the 107 patients involved in the study (mean age 51.1 ± 8.4 years; 78.5 % Chinese), 46.7 % manifested non-cancer comorbidities, of which hypertension (24.3 %) was the most prevalent, followed by hyperlipidemia (13.1 %) and diabetes (5.6 %). Calcium channel blockers (12.1 %) and lipid-modifying agents (11.2 %) were the most common chronic medication types used before chemotherapy, and their use persisted during chemotherapy (10.3 and 11.2 %, respectively) and after chemotherapy (11.2 and 13.1 %, respectively). Hormonal therapy was the predominant post-chemotherapy medication (77.6 %). A statistically significant increase (
There is an increase in trend of chronic medication usage in breast cancer survivors after cancer treatment. This study provides important insights into the design of medication management programs tailored to this population. Future studies should incorporate a control population to improve the interpretation of study results.
Url:
DOI: 10.1007/s00520-015-2950-z
PubMed: 26404861
PubMed Central: 4766201
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000E67
- to stream Pmc, to step Curation: 000E66
- to stream Pmc, to step Checkpoint: 001071
- to stream Ncbi, to step Merge: 007935
- to stream Ncbi, to step Curation: 007935
- to stream Ncbi, to step Checkpoint: 007935
- to stream Main, to step Merge: 001B08
- to stream Main, to step Curation: 001B05
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Medication use by early-stage breast cancer survivors: a 1-year longitudinal study</title><author><name sortKey="Loh, Kep Yong" sort="Loh, Kep Yong" uniqKey="Loh K" first="Kep Yong" last="Loh">Kep Yong Loh</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation></author><author><name sortKey="Ng, Terence" sort="Ng, Terence" uniqKey="Ng T" first="Terence" last="Ng">Terence Ng</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="Aff2">Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore, 117543 Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore</wicri:regionArea><orgName type="university">Université nationale de Singapour</orgName></affiliation></author><author><name sortKey="Lee, Chee Ping" sort="Lee, Chee Ping" uniqKey="Lee C" first="Chee Ping" last="Lee">Chee Ping Lee</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation></author><author><name sortKey="Ng, Raymond" sort="Ng, Raymond" uniqKey="Ng R" first="Raymond" last="Ng">Raymond Ng</name><affiliation wicri:level="1"><nlm:aff id="Aff3">Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Division of Medical Oncology, National Cancer Centre Singapore, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation></author><author><name sortKey="Chan, Alexandre" sort="Chan, Alexandre" uniqKey="Chan A" first="Alexandre" last="Chan">Alexandre Chan</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="Aff2">Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore, 117543 Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore</wicri:regionArea><orgName type="university">Université nationale de Singapour</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26404861</idno><idno type="pmc">4766201</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766201</idno><idno type="RBID">PMC:4766201</idno><idno type="doi">10.1007/s00520-015-2950-z</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000E67</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000E67</idno><idno type="wicri:Area/Pmc/Curation">000E66</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000E66</idno><idno type="wicri:Area/Pmc/Checkpoint">001071</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001071</idno><idno type="wicri:Area/Ncbi/Merge">007935</idno><idno type="wicri:Area/Ncbi/Curation">007935</idno><idno type="wicri:Area/Ncbi/Checkpoint">007935</idno><idno type="wicri:doubleKey">0941-4355:2015:Loh K:medication:use:by</idno><idno type="wicri:Area/Main/Merge">001B08</idno><idno type="wicri:Area/Main/Curation">001B05</idno><idno type="wicri:Area/Main/Exploration">001B05</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Medication use by early-stage breast cancer survivors: a 1-year longitudinal study</title><author><name sortKey="Loh, Kep Yong" sort="Loh, Kep Yong" uniqKey="Loh K" first="Kep Yong" last="Loh">Kep Yong Loh</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation></author><author><name sortKey="Ng, Terence" sort="Ng, Terence" uniqKey="Ng T" first="Terence" last="Ng">Terence Ng</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="Aff2">Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore, 117543 Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore</wicri:regionArea><orgName type="university">Université nationale de Singapour</orgName></affiliation></author><author><name sortKey="Lee, Chee Ping" sort="Lee, Chee Ping" uniqKey="Lee C" first="Chee Ping" last="Lee">Chee Ping Lee</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation></author><author><name sortKey="Ng, Raymond" sort="Ng, Raymond" uniqKey="Ng R" first="Raymond" last="Ng">Raymond Ng</name><affiliation wicri:level="1"><nlm:aff id="Aff3">Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Division of Medical Oncology, National Cancer Centre Singapore, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation></author><author><name sortKey="Chan, Alexandre" sort="Chan, Alexandre" uniqKey="Chan A" first="Alexandre" last="Chan">Alexandre Chan</name><affiliation wicri:level="1"><nlm:aff id="Aff1">Department of Pharmacy, National Cancer Centre, Singapore, Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, National Cancer Centre, Singapore</wicri:regionArea><wicri:noRegion>Singapore</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="Aff2">Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore, 117543 Singapore</nlm:aff><country xml:lang="fr">Singapour</country><wicri:regionArea>Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, Singapore</wicri:regionArea><orgName type="university">Université nationale de Singapour</orgName></affiliation></author></analytic><series><title level="j">Supportive Care in Cancer</title><idno type="ISSN">0941-4355</idno><idno type="eISSN">1433-7339</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Purpose</title><p>The aim of this study is to characterize the patterns of medication use by early-stage breast cancer (ESBC) survivors from diagnosis to 1 year post-chemotherapy.</p></sec><sec><title>Methods</title><p>A single-center longitudinal study was conducted with ESBC patients diagnosed between December 2011 and June 2014. Data on the medication use of individual patients were retrieved from prescription databases, supplemented by records from the National Electronic Health Records. The data covered the period from ESBC diagnosis to 1 year post-chemotherapy. Medication types were classified according to the World Health Organization’s Anatomical Therapeutic Chemical classification system, and medication for chronic diseases was created by adapting a list of 20 chronic diseases provided by the U.S. Department of Human and Health Services.</p></sec><sec><title>Results</title><p>Of the 107 patients involved in the study (mean age 51.1 ± 8.4 years; 78.5 % Chinese), 46.7 % manifested non-cancer comorbidities, of which hypertension (24.3 %) was the most prevalent, followed by hyperlipidemia (13.1 %) and diabetes (5.6 %). Calcium channel blockers (12.1 %) and lipid-modifying agents (11.2 %) were the most common chronic medication types used before chemotherapy, and their use persisted during chemotherapy (10.3 and 11.2 %, respectively) and after chemotherapy (11.2 and 13.1 %, respectively). Hormonal therapy was the predominant post-chemotherapy medication (77.6 %). A statistically significant increase (<italic>p</italic> < 0.0001) was observed in the mean number of chronic disease medication classes prescribed to patients between the pre-chemotherapy (0.53 ± 1.04) and chemotherapy (0.62 ± 1.08) periods and between the chemotherapy and post-chemotherapy (1.63 ± 1.35) periods.</p></sec><sec><title>Conclusions</title><p>There is an increase in trend of chronic medication usage in breast cancer survivors after cancer treatment. This study provides important insights into the design of medication management programs tailored to this population. Future studies should incorporate a control population to improve the interpretation of study results.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Bray, F" uniqKey="Bray F">F Bray</name></author><author><name sortKey="Ren, Js" uniqKey="Ren J">JS Ren</name></author><author><name sortKey="Masuyer, E" uniqKey="Masuyer E">E Masuyer</name></author><author><name sortKey="Ferlay, J" uniqKey="Ferlay J">J Ferlay</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Wv" uniqKey="Wang W">WV Wang</name></author><author><name sortKey="Tan, Sm" uniqKey="Tan S">SM Tan</name></author><author><name sortKey="Chow, Wl" uniqKey="Chow W">WL Chow</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Riemsma, R" uniqKey="Riemsma R">R Riemsma</name></author><author><name sortKey="Forbes, Ca" uniqKey="Forbes C">CA Forbes</name></author><author><name sortKey="Kessels, A" uniqKey="Kessels A">A Kessels</name></author><author><name sortKey="Lykopoulos, K" uniqKey="Lykopoulos K">K Lykopoulos</name></author><author><name sortKey="Amonkar, Mm" uniqKey="Amonkar M">MM Amonkar</name></author><author><name sortKey="Rea, Dw" uniqKey="Rea D">DW Rea</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ganz, Pa" uniqKey="Ganz P">PA Ganz</name></author><author><name sortKey="Hahn, Ee" uniqKey="Hahn E">EE Hahn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Erikson, C" uniqKey="Erikson C">C Erikson</name></author><author><name sortKey="Salsberg, E" uniqKey="Salsberg E">E Salsberg</name></author><author><name sortKey="Forte, G" uniqKey="Forte G">G Forte</name></author><author><name sortKey="Bruinooge, S" uniqKey="Bruinooge S">S Bruinooge</name></author><author><name sortKey="Goldstein, M" uniqKey="Goldstein M">M Goldstein</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Weaver, Ke" uniqKey="Weaver K">KE Weaver</name></author><author><name sortKey="Forsythe, Lp" uniqKey="Forsythe L">LP Forsythe</name></author><author><name sortKey="Reeve, Bb" uniqKey="Reeve B">BB Reeve</name></author><author><name sortKey="Alfano, Cm" uniqKey="Alfano C">CM Alfano</name></author><author><name sortKey="Rodriguez, Jl" uniqKey="Rodriguez J">JL Rodriguez</name></author><author><name sortKey="Sabatino, Sa" uniqKey="Sabatino S">SA Sabatino</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Beckjord, E" uniqKey="Beckjord E">E Beckjord</name></author><author><name sortKey="Reynolds, L" uniqKey="Reynolds L">L Reynolds</name></author><author><name sortKey="Van Londen, G" uniqKey="Van Londen G">G van Londen</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Otte, Jl" uniqKey="Otte J">JL Otte</name></author><author><name sortKey="Skaar, Tc" uniqKey="Skaar T">TC Skaar</name></author><author><name sortKey="Wu, J" uniqKey="Wu J">J Wu</name></author><author><name sortKey="Yu, M" uniqKey="Yu M">M Yu</name></author><author><name sortKey="Ryker, K" uniqKey="Ryker K">K Ryker</name></author><author><name sortKey="Burns, Ds" uniqKey="Burns D">DS Burns</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, Ww" uniqKey="Chen W">WW Chen</name></author><author><name sortKey="Shao, Yy" uniqKey="Shao Y">YY Shao</name></author><author><name sortKey="Shau, Wy" uniqKey="Shau W">WY Shau</name></author><author><name sortKey="Lin, Zz" uniqKey="Lin Z">ZZ Lin</name></author><author><name sortKey="Lu, Ys" uniqKey="Lu Y">YS Lu</name></author><author><name sortKey="Chen, Hm" uniqKey="Chen H">HM Chen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Singla, A" uniqKey="Singla A">A Singla</name></author><author><name sortKey="Kumar, G" uniqKey="Kumar G">G Kumar</name></author><author><name sortKey="Bardia, A" uniqKey="Bardia A">A Bardia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Catt, S" uniqKey="Catt S">S Catt</name></author><author><name sortKey="Fallowfield, L" uniqKey="Fallowfield L">L Fallowfield</name></author><author><name sortKey="Langridge, C" uniqKey="Langridge C">C Langridge</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Berglund, A" uniqKey="Berglund A">A Berglund</name></author><author><name sortKey="Wigertz, A" uniqKey="Wigertz A">A Wigertz</name></author><author><name sortKey="Adolfsson, J" uniqKey="Adolfsson J">J Adolfsson</name></author><author><name sortKey="Ahlgren, J" uniqKey="Ahlgren J">J Ahlgren</name></author><author><name sortKey="Fornander, T" uniqKey="Fornander T">T Fornander</name></author><author><name sortKey="W Rnberg, F" uniqKey="W Rnberg F">F Wärnberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cheung, Yt" uniqKey="Cheung Y">YT Cheung</name></author><author><name sortKey="Ng, T" uniqKey="Ng T">T Ng</name></author><author><name sortKey="Shwe, M" uniqKey="Shwe M">M Shwe</name></author><author><name sortKey="Ho, Hk" uniqKey="Ho H">HK Ho</name></author><author><name sortKey="Foo, Km" uniqKey="Foo K">KM Foo</name></author><author><name sortKey="Cham, Mt" uniqKey="Cham M">MT Cham</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Goodman, Ra" uniqKey="Goodman R">RA Goodman</name></author><author><name sortKey="Posner, Sf" uniqKey="Posner S">SF Posner</name></author><author><name sortKey="Huang, Es" uniqKey="Huang E">ES Huang</name></author><author><name sortKey="Parekh, Ak" uniqKey="Parekh A">AK Parekh</name></author><author><name sortKey="Koh, Hk" uniqKey="Koh H">HK Koh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stein, Kd" uniqKey="Stein K">KD Stein</name></author><author><name sortKey="Syrjala, Kl" uniqKey="Syrjala K">KL Syrjala</name></author><author><name sortKey="Andrykowski, Ma" uniqKey="Andrykowski M">MA Andrykowski</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Valdivieso, M" uniqKey="Valdivieso M">M Valdivieso</name></author><author><name sortKey="Kujawa, Am" uniqKey="Kujawa A">AM Kujawa</name></author><author><name sortKey="Jones, T" uniqKey="Jones T">T Jones</name></author><author><name sortKey="Baker, Lh" uniqKey="Baker L">LH Baker</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Cooper, C" uniqKey="Cooper C">C Cooper</name></author><author><name sortKey="Snow, S" uniqKey="Snow S">S Snow</name></author><author><name sortKey="Mcalindon, Te" uniqKey="Mcalindon T">TE McAlindon</name></author><author><name sortKey="Kellingray, S" uniqKey="Kellingray S">S Kellingray</name></author><author><name sortKey="Stuart, B" uniqKey="Stuart B">B Stuart</name></author><author><name sortKey="Coggon, D" uniqKey="Coggon D">D Coggon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Blagojevic, M" uniqKey="Blagojevic M">M Blagojevic</name></author><author><name sortKey="Jinks, C" uniqKey="Jinks C">C Jinks</name></author><author><name sortKey="Jeffery, A" uniqKey="Jeffery A">A Jeffery</name></author><author><name sortKey="Jordan, Kp" uniqKey="Jordan K">KP Jordan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Murphy, Cc" uniqKey="Murphy C">CC Murphy</name></author><author><name sortKey="Bartholomew, Lk" uniqKey="Bartholomew L">LK Bartholomew</name></author><author><name sortKey="Carpentier, My" uniqKey="Carpentier M">MY Carpentier</name></author><author><name sortKey="Bluethmann, Sm" uniqKey="Bluethmann S">SM Bluethmann</name></author><author><name sortKey="Vernon, Sw" uniqKey="Vernon S">SW Vernon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Perreault, S" uniqKey="Perreault S">S Perreault</name></author><author><name sortKey="Lamarre, D" uniqKey="Lamarre D">D Lamarre</name></author><author><name sortKey="Blais, L" uniqKey="Blais L">L Blais</name></author><author><name sortKey="Dragomir, A" uniqKey="Dragomir A">A Dragomir</name></author><author><name sortKey="Berbiche, D" uniqKey="Berbiche D">D Berbiche</name></author><author><name sortKey="Lalonde, L" uniqKey="Lalonde L">L Lalonde</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Ganz, Pa" uniqKey="Ganz P">PA Ganz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chalasani, P" uniqKey="Chalasani P">P Chalasani</name></author><author><name sortKey="Downey, L" uniqKey="Downey L">L Downey</name></author><author><name sortKey="Stopeck, At" uniqKey="Stopeck A">AT Stopeck</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lyon, De" uniqKey="Lyon D">DE Lyon</name></author><author><name sortKey="Roux, G" uniqKey="Roux G">G Roux</name></author><author><name sortKey="Voll, S" uniqKey="Voll S">S Voll</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Khatcheressian, Jl" uniqKey="Khatcheressian J">JL Khatcheressian</name></author><author><name sortKey="Hurley, P" uniqKey="Hurley P">P Hurley</name></author><author><name sortKey="Bantug, E" uniqKey="Bantug E">E Bantug</name></author><author><name sortKey="Esserman, Lj" uniqKey="Esserman L">LJ Esserman</name></author><author><name sortKey="Grunfeld, E" uniqKey="Grunfeld E">E Grunfeld</name></author><author><name sortKey="Halberg, F" uniqKey="Halberg F">F Halberg</name></author></analytic></biblStruct></listBibl></div1></back></TEI><affiliations><list><country><li>Singapour</li></country><orgName><li>Université nationale de Singapour</li></orgName></list><tree><country name="Singapour"><noRegion><name sortKey="Loh, Kep Yong" sort="Loh, Kep Yong" uniqKey="Loh K" first="Kep Yong" last="Loh">Kep Yong Loh</name></noRegion><name sortKey="Chan, Alexandre" sort="Chan, Alexandre" uniqKey="Chan A" first="Alexandre" last="Chan">Alexandre Chan</name><name sortKey="Chan, Alexandre" sort="Chan, Alexandre" uniqKey="Chan A" first="Alexandre" last="Chan">Alexandre Chan</name><name sortKey="Lee, Chee Ping" sort="Lee, Chee Ping" uniqKey="Lee C" first="Chee Ping" last="Lee">Chee Ping Lee</name><name sortKey="Ng, Raymond" sort="Ng, Raymond" uniqKey="Ng R" first="Raymond" last="Ng">Raymond Ng</name><name sortKey="Ng, Terence" sort="Ng, Terence" uniqKey="Ng T" first="Terence" last="Ng">Terence Ng</name><name sortKey="Ng, Terence" sort="Ng, Terence" uniqKey="Ng T" first="Terence" last="Ng">Terence Ng</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4766201
|texte= Medication use by early-stage breast cancer survivors: a 1-year longitudinal study
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26404861" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |